As of Feb 24
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Windtree Therapeutics Inc have a median target of 3.30, with a high estimate of 3.30 and a low estimate of 3.30. The median estimate represents a +170.49% increase from the last price of 1.22.
The current consensus among 1 polled investment analysts is to Buy stock in Windtree Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.